These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11358931)

  • 1. Mechanisms of carvedilol action in human congestive heart failure.
    Kaye DM; Johnston L; Vaddadi G; Brunner-LaRocca H; Jennings GL; Esler MD
    Hypertension; 2001 May; 37(5):1216-21. PubMed ID: 11358931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.
    Al-Nasser F; Yousufuddin M; Al-Nozha F; Anker SD; Coats AJ; Piepoli MF; Ponikowski PP
    Am J Cardiol; 2003 May; 91(10):1281-3. PubMed ID: 12745124
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER; Kubo T; Mak S; Al-Hesayen A; Schofield A; Allan R; Kelly S; Newton GE; Floras JS; Parker JD
    Circulation; 2001 Oct; 104(18):2194-9. PubMed ID: 11684630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.
    Wallhaus TR; Taylor M; DeGrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    Circulation; 2001 May; 103(20):2441-6. PubMed ID: 11369683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
    Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
    Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
    Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
    Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.
    Cohen-Solal A; Rouzet F; Berdeaux A; Le Guludec D; Abergel E; Syrota A; Merlet P
    J Nucl Med; 2005 Nov; 46(11):1796-803. PubMed ID: 16269592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-blockade restores muscle sympathetic rhythmicity in human heart failure.
    Kubo T; Azevedo ER; Newton GE; Picton P; Parker JD; Floras JS
    Circ J; 2011; 75(6):1400-8. PubMed ID: 21519151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.